Oppenheimer Downgrades Questcor Pharmaceuticals (QCOR) to Perform after Probe

September 24, 2012 10:14 AM EDT Send to a Friend
Get Alerts QCOR Hot Sheet
Price: $93.60 --0%

Rating Summary:
    7 Buy, 9 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade QCOR Now!
Join SI Premium – FREE
Oppenheimer downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Outperform to Perform following the U.S. probe into marketing practices.

For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.

Shares of Questcor Pharmaceuticals closed at $30.13 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Add Your Comment